Southwell David P

Southwell David P is listed in filings as Director at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including 4 public disclosures. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT) and Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Jun 20, 2024 to Jan 6, 2026. Reported amounts are shown as $266.7K to $547.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.